Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes

OBJECTIVE: Advances in diabetes technology have transformed the treatment paradigm for type 1 diabetes, yet the burden of disease is significant. We report on a pivotal safety study of the first tubeless, on-body automated insulin delivery system with customizable glycemic targets. RESEARCH DESIGN A...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Sue A., Forlenza, Gregory P., Bode, Bruce W., Pinsker, Jordan E., Levy, Carol J., Criego, Amy B., Hansen, David W., Hirsch, Irl B., Carlson, Anders L., Bergenstal, Richard M., Sherr, Jennifer L., Mehta, Sanjeev N., Laffel, Lori M., Shah, Viral N., Bhargava, Anuj, Weinstock, Ruth S., MacLeish, Sarah A., DeSalvo, Daniel J., Jones, Thomas C., Aleppo, Grazia, Buckingham, Bruce A., Ly, Trang T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2021
Materias:
Emerging Technologies: Data Systems and Devices
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323171/
https://www.ncbi.nlm.nih.gov/pubmed/34099518
http://dx.doi.org/10.2337/dc21-0172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323171/
https://www.ncbi.nlm.nih.gov/pubmed/34099518
http://dx.doi.org/10.2337/dc21-0172

Ejemplares similares